Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Andrology

  Free Subscription


Articles published in Eur J Cancer

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    May 2018
  1. FRAZIER AL, Stoneham S, Rodriguez-Galindo C, Dang H, et al
    Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium.
    Eur J Cancer. 2018;98:30-37.
    PubMed     Text format     Abstract available


    March 2018
  2. ALIFRANGIS C, Wilson P, Shamash J
    Letter to the Editor: Central nervous system relapse rate and dose intensification in poor risk metastatic germ cell tumours-A comment on: 'Patterns of relapse in poor prognosis germ cell tumours in the GETUG-13 trial: Implications for the assessment
    Eur J Cancer. 2018 Mar 31. pii: S0959-8049(18)30226.
    PubMed     Text format    


  3. FRESNEAU B, Orbach D, Faure-Conter C, Sudour-Bonnange H, et al
    Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
    Eur J Cancer. 2018;95:11-19.
    PubMed     Text format     Abstract available


  4. SEIDEL C, Daugaard G, Tryakin A, Necchi A, et al
    Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors.
    Eur J Cancer. 2018;94:16-25.
    PubMed     Text format     Abstract available


  5. ABIUSO AMB, Varela ML, Haro Durand L, Besio Moreno M, et al
    Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys.
    Eur J Cancer. 2018;91:125-135.
    PubMed     Text format     Abstract available


    January 2018
  6. DUHIL DE BENAZE G, Pacquement H, Faure-Conter C, Patte C, et al
    Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects study.
    Eur J Cancer. 2018;91:30-37.
    PubMed     Text format     Abstract available


    November 2017
  7. LORIOT Y, Pagliaro L, Flechon A, Mardiak J, et al
    Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.
    Eur J Cancer. 2017;87:140-146.
    PubMed     Text format     Abstract available


    October 2017
  8. DE LA PENA H, Sharma A, Glicksman C, Joseph J, et al
    No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer.
    Eur J Cancer. 2017;84:354-359.
    PubMed     Text format     Abstract available


  9. VERMEULEN RFM, Beurden MV, Kieffer JM, Bleiker EMA, et al
    Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study.
    Eur J Cancer. 2017;84:159-167.
    PubMed     Text format     Abstract available


    July 2017
  10. BANDAK M, Jorgensen N, Juul A, Lauritsen J, et al
    Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivors.
    Eur J Cancer. 2017;84:9-17.
    PubMed     Text format     Abstract available


    May 2017
  11. ZSCHABITZ S, Lasitschka F, Hadaschik B, Hofheinz RD, et al
    Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
    Eur J Cancer. 2017;76:1-7.
    PubMed     Text format     Abstract available


    March 2017
  12. GIZZI M, Oberic L, Massard C, Poterie A, et al
    Corrigendum to "Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours" [Eur J Cancer 69 (2016) 151-157].
    Eur J Cancer. 2017 Mar 7. pii: S0959-8049(17)30740.
    PubMed     Text format    


    November 2016
  13. GIZZI M, Oberic L, Massard C, Poterie A, et al
    Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours.
    Eur J Cancer. 2016;69:151-157.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: